Lung transplantation: management and complications.
Lung transplantation has become an accepted treatment modality for end stage lung disease including emphysema, fibrosing alveolitis, cystic fibrosis, pulmonary hypertension and bronchiectasis. Despite the use of potent immunosuppressive drugs, acute rejection occurs frequently, especially in the first few weeks and months after transplantation. Bacterial, viral and fungal infections frequently occur in lung transplant recipients. Rapid diagnosis and adequate treatment of infections is needed. The side effects with the use of long term immunosuppressive agents includes renal toxicity, hypertension, neurotoxicity, hyperlipidemia, leucopoenia, hyperglycaemia, weight gain, osteoporosis and malignancy. However, obliterative bronchiolitis (OB) which is regarded as a chronic rejection process remains the dominant cause of morbidity and mortality in the long-term survivors of lung transplantation. This article focuses on the postoperative and long term management of lung transplant recipients.
Chhajed
P N
PN
The Lung Transplant Unit, St Vincent's Hospital, NSW, Sydney, Australia.
Tamm
M
M
Malouf
M A
MA
Glanville
A R
AR
D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects* / Q000534:rehabilitation*; D011182:Postoperative Care; D011183:Postoperative Complications; D013997:Time Factors